The trauma fixation devices market is set to witness sturdy expansion by 2027 on account of increasing incidences of injuries. In addition, growing geriatric population across the globe is estimated to support market development over the forecast period.

Recently, notable technological advancements in trauma fixation devices and the advent of bioabsorbable fixation devices, which are entirely absorbable implants that eliminate the need for any removal surgery or long-term interference with bones, muscles, or tendons, have propelled product demand. Subsequently, increasing penetration of bioabsorbable fixation devices in bone and trauma surgery has driven industry uptake in recent years.

Moreover, industry participants have been employing lucrative strategies to gain a competitive edge in the rapidly evolving marketplace, which has favorably impacted the overall business landscape. For instance, in August 2021, Zimmer Biomet Holdings Inc., a major medical technology company, received FDA clearance for its novel orthopedic robotic solution for total hip arthroplasty, dubbed the ROSA Hip system. The ROSA Hip system has been designed to aid anterior surgeons with the placement, preparation, and component impaction while measuring cup orientation, leg length, and offset intra-operatively.

The trauma fixation devices market has been segmented on the basis of end-use, product, site, material, and region. From the product perspective, the market has further been divided into internal fixators, external fixators, and others. The external fixators sub-segment is expected to showcase robust growth in the coming years and attain a valuation of around USD 3,617.3 million by the end of 2027.

In terms of material, the trauma fixation devices market has been categorized into titanium, stainless steel, and others. In 2020, the titanium sub-segment garnered nearly USD 2,507.9 million in revenue and is estimated to exhibit a solid growth trajectory over the assessment timeframe.

Based on site, the market has been segregated into upper extremities and lower extremities. The trauma fixation devices industry share from the lower extremities sub-segment is anticipated to reach a sizable estimation of more than USD 5,179.7 million by the end of 2027.

With respect to end-use, the trauma fixation devices market has been bifurcated into orthopedic centers, hospitals, ambulatory surgical centers, and others. The hospitals sub-segment is poised to be worth over USD 3,048.5 million by the end of 2027.

From the regional point of view, the Latin America trauma fixation devices market held a share of about 7.3% in the overall industry in 2020 and is speculated to progress at a considerable pace over 2021-2027. The Middle East & Africa trauma fixation devices market is foreseen to reach a substantial valuation by 2027, developing at approximately 6.7% CAGR through the forecast timeframe.